Clinical Trial Protocol for HyNOVA: Hyperthermic and Normothermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III epithelial OVArian, fallopian tube and primary peritoneal cancer (ANZGOG1901/2020).

Saved in:
Bibliographic Details
Title: Clinical Trial Protocol for HyNOVA: Hyperthermic and Normothermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III epithelial OVArian, fallopian tube and primary peritoneal cancer (ANZGOG1901/2020).
Authors: Farrell R; Chris O'Brien Lifehouse, Sydney, Australia.; University of Sydney, Sydney, Australia. rhondafarrell@mac.com., Burling M; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.; Department of Gynecological Oncology, Westmead Hospital, Sydney, Australia., Lee YC; Chris O'Brien Lifehouse, Sydney, Australia.; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia., Pather S; Chris O'Brien Lifehouse, Sydney, Australia.; University of Sydney, Sydney, Australia., Robledo K; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia., Mercieca-Bebber R; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia., Stockler M; Chris O'Brien Lifehouse, Sydney, Australia.; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.
Corporate Authors: HyNOVA Protocol Steering Committee
Source: Journal of gynecologic oncology [J Gynecol Oncol] 2022 Jan; Vol. 33 (1), pp. e1. Date of Electronic Publication: 2021 Oct 18.
Publication Type: Clinical Trial Protocol; Journal Article
Journal Info: Publisher: Asian Society of Gynecologic Oncology Country of Publication: Korea (South) NLM ID: 101483150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2005-0399 (Electronic) Linking ISSN: 20050380 NLM ISO Abbreviation: J Gynecol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2005-0399
DOI:10.3802/jgo.2022.33.e1